Bax inhibitor peptide V5

BAX Inhibiting Peptide V5 protects Bax against conformational changes and it also prevents mitochondrial translocation. In vitro analysis prove that peptide V5 prevents apoptosis, mediated by a number of agents including staurosporine, ultraviolet, and anti-cancer drug.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Bax inhibitor peptide V5(CAS 579492-81-2)

CAT No: R1852

CAS No:579492-81-2

Synonyms/Alias:Bax inhibitor peptide V5;579492-81-2;Val-Pro-Met-Leu-Lys;(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-4-methylsulfanylbutanoyl]amino]-4-methylpentanoyl]amino]hexanoic acid;BIP-V5;BIP-V5;BAX Inhibiting Peptide V5;Bax inhibitor peptide V5?;HY-P0081;BAX Inhibiting Peptide V5; BIP-V5;AKOS024456777;CS-5509;DA-61502;D83676;

Chemical Name:(S)-6-amino-2-((Z)-((S)-2-((Z)-((S)-2-((Z)-(((S)-1-((S)-2-amino-3-methylbutanoyl)pyrrolidin-2-yl)(hydroxy)methylene)amino)-1-hydroxy-4-(methylthio)butylidene)amino)-1-hydroxy-4-methylpentylidene)amino)hexanoic acid

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C27H50N6O6S
M.W/Mr.
586.8
Sequence
One Letter Code:VPMLK
Three Letter Code:H-Val-Pro-Met-Leu-Lys-OH
Labeling Target
Apoptosis
Appearance
Crystalline solid
Purity
≥97% (HPLC)
Activity
Inhibitor
Areas of Interest
Cancer
Source#
Synthetic
Long-term Storage Conditions
≥29.35mg/mL in DMSO,insoluble in EtOH, ≥91.4 mg/mL in H2O
Shipping Condition
Evaluation sample solution : ship with blue ice; All other available size: ship with RT , or blue ice upon request
Solubility
-20 °C
InChI
InChI=1S/C27H50N6O6S/c1-16(2)15-20(24(35)31-19(27(38)39)9-6-7-12-28)32-23(34)18(11-14-40-5)30-25(36)21-10-8-13-33(21)26(37)22(29)17(3)4/h16-22H,6-15,28-29H2,1-5H3,(H,30,36)(H,31,35)(H,32,34)(H,38,39)/t18-,19-,20-,21-,22-/m0/s1
InChI Key
NHMUTADCTDDWPV-YFNVTMOMSA-N
Canonical SMILES
CC(C)CC(C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCSC)NC(=O)C1CCCN1C(=O)C(C(C)C)N
Isomeric SMILES
CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)C)N
BoilingPoint
N/A
References
Sawatzky DA, et al. The involvement of the apoptosis-modulating proteins ERK 1/2, Bcl-xL and Bax in the resolution of acute inflammation in vivo. The American Journal of Pathology. 2006; 168(1):33-41.
Melting Point
N/A

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Custom Conjugation ServicePeptide CDMOPeptide Modification ServicescGMP Peptide ServicePeptide Analysis ServicesEpitope Mapping ServicesPeptide Synthesis ServicesPeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers